Health Care Center, Kitasato University, Kanagawa, Japan.
Yamagishi Clinic, Kanagawa, Japan.
J Diabetes Complications. 2019 May;33(5):368-373. doi: 10.1016/j.jdiacomp.2019.02.002. Epub 2019 Feb 10.
The aim of the present study was to explore the relationship between changes in renal structure in patients with type 2 diabetes at an early stage of diabetic nephropathy using serial renal biopsies, and change in renal function.
The study population comprised 10 patients with type 2 diabetes with normo- or microalbuminuria at baseline. Light and electron microscopy-based morphometric analyses were performed to quantitatively evaluate glomerular and interstitial structural changes. Urinary albumin excretion (UAE) and glomerular filtration rate (GFR) were measured annually. A second renal biopsy was performed after a mean of 6.1 ± 2.4 years of follow-up.
UAE, GFR, blood pressure and severity of diabetic retinopathy (DR) did not change between the baseline and follow-up. The annual decrease in the surface density of the peripheral glomerular basement membrane (GBM) (Sv[PGBM/glom]) was correlated with the rate of loss of GFR during the six-year follow-up period. The annual change in the Sv(PGBM/glom) was negatively correlated with the change in mesangial volume fraction.
Decreases in the GFR in patients with type 2 diabetes with normo- or microalbuminuria at baseline were associated with a decreased glomerular filtration surface, as a result of mesangial expansion during a mean six years of observation. These findings confirm ongoing pathological progression of glomerulopathy despite no significant change in albuminuria or retinopathy status.
本研究旨在通过对早期糖尿病肾病患者的连续肾活检,探讨其肾结构变化与肾功能变化的关系。
研究对象为 10 例初诊时伴有正常或微量白蛋白尿的 2 型糖尿病患者。采用光镜和电镜形态计量学分析,定量评价肾小球和间质结构变化。每年测量尿白蛋白排泄率(UAE)和肾小球滤过率(GFR)。平均随访 6.1±2.4 年后进行第二次肾活检。
UAE、GFR、血压和糖尿病视网膜病变(DR)严重程度在基线和随访期间均无变化。外周肾小球基底膜(GBM)表面积密度的年下降率(Sv[PGBM/glom])与 6 年随访期间 GFR 的下降率相关。Sv(PGBM/glom)的年变化与系膜体积分数的变化呈负相关。
在基线时伴有正常或微量白蛋白尿的 2 型糖尿病患者中,GFR 的下降与肾小球滤过面积的减少有关,这是由于在平均 6 年的观察期间系膜扩张所致。这些发现证实了肾小球病的持续病理进展,尽管白蛋白尿或视网膜病变状态没有明显变化。